EUDA Company Profile and Key Details

EUDA Health Holdings Limited has 2.99 million shares outstanding. The public float is 1.11 million shares, elevated short interest at 0.25% of float. This equals 5.08 thousand shares. The short ratio is 1.48 days. Institutional investors hold 0.0% of the float. Insiders own 49.42%.

Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $6.00 to $6.00. The high target offers -61.04% upside. The low target suggests -61.04% downside. The mean target is $6.00. This offers -61.04% upside. EUDA Health Holdings Limited earnings surprise history is a consistent trend of beating forecasts. The quarter that ended April 28, 2026, missed forecasts by 0.0%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include 0.0% in October 18, 2024.

EUDA has shown weak momentum, losing -30.74% over the past week and -49.1% over the past quarter, though year-to-date performance is down -26.84%. Short-term trend indicators are bullishly aligned (SMA20 -10.8%, SMA50 -45.48%, SMA200 -64.01%). The stock’s 14-day RSI is 34.86 (weak momentum), while the ATR of 0.17 points to moderate volatility. The stock remains hovering near 52-week lows, trading -78.88% below its high and over 27.9% above its low. Average 10-day trading volume of 4.37 thousand shares is in line with the 3-month average of 4.64 thousand, indicating normal recent market interest.

EUDA Health Holdings Limited last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$1.44. This means the shares are trading below this model’s fair value.

EUDA Health Holdings Limited (NASDAQ:EUDA) closed at $15.40 USD, gaining $2.19 (16.58%) from the previous close of $13.21. The stock is currently mid-range between its 52-week high and low $5.26 and $86.00. With a market capitalization of about $28.76 million, EUDA Health Holdings Limited is classified as a micro-cap and shows lower-than-market volatility (beta ~0.64). Key stats such as the average daily volume over the past year has been around 4.61 thousand shares, trading with heavier-than-usual volume. Headquartered in Singapore, CE, EUDA Health Holdings Limited operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Alfred Lim, the company employs approximately 123 people and listed since December 14, 2021. EUDA Health Limited, established in 2019, is a Singapore-based enterprise dedicated to advancing digital healthcare.

EUDA Health Holdings Limited trades at a P/E ratio of -5.92, slightly below the S&P 500 average, with a price-to-sales ratio of 2.4 and a price-to-book ratio of -6.61 indicating negative book value, which may reflect financial stress. The P/FCF stands at -6.46, also below market averages.

Our AI price prediction model suggests that EUDA Health Holdings Limited stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 1.82%, with price expected at $15.68 by September 07, 2026, within a range of $12.85 to $18.63 3-Month Outlook: Projected rise of 120.84%, reaching $34.01 by November 20, 2026, with a range of $31.32 to $36.73. 1-Year Outlook: Projected loss of -24.87%, with price at $11.57 by August 24, 2027, within a range of $1.94 to $23.65.

EUDA Health Holdings Limited (NASDAQ:EUDA) shares are down -26.84% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows EUDA Health Holdings Limited trading at a premium to the broader market with a P/E of -5.92. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $6.00, suggesting -61.04% downside. Our AI forecast model points to short-term strength (1.82% over two weeks), a medium-term rise (120.84% over three months), and a longer-term loss (-24.87% over one year), with expected trading ranges indicating moderate volatility.